Spiro[indene-1,4'-piperidine] hydrochloride

Catalog No. :
ACNYDL409
CAS No. :
137730-67-7
Molecular Formula :
C13H16ClN
Molecular Weight :
221.73

IUPAC Name:spiro[indene-1,4'-piperidine] hydrochloride

Spiro[indene-1,4'-piperidine] hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$51.00Login to see priceIn stockInquiry
5g95%$214.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSpiro[indene-1,4'-piperidine] hydrochloride
IUPAC Namespiro[indene-1,4'-piperidine] hydrochloride
MDL No.MFCD01632538
Molecular FormulaC13H16ClN
Molecular Weight221.73
SMILESCl.C1CC2(CCN1)C=CC1=CC=CC=C21
InChI KeyCNFMPMUITJAJKC-UHFFFAOYSA-N
Synonymspiro[indene-1,4'-piperidine] hydrochloride | 137730-67-7 | 4-spiroindene-piperidine hydrochloride | Spiro[indene-1,4'-piperidine] HCl | spiro[indene-1,4'-piperidine]hydrochloride | spiro[indene-1,4'-piperidine];hydrochloride | MFCD01632538 | Spiro[1H-indene-1,4'-piper
CAS No.137730-67-7
PubChem CID22509344

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACNYDL409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOGJS732 route compound structure diagram
    ACOGJS732137419-24-0 In Stock
  2. Then
  3. ACNYDL409 route product structure diagram
    ACNYDL409137730-67-7 In Stock
Inquiry

2. ACNYDL409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOGJS732 route compound structure diagram
    ACOGJS732137419-24-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBAUS147 route compound structure diagram
    ACBAUS1472923-16-2 In Stock
  6. Then
  7. ACNYDL409 route product structure diagram
    ACNYDL409137730-67-7 In Stock
Inquiry

Comments (0)